Srivatsan Ramesh

Srivatsan Ramesh is a downstream process development scientist with BridgeBio gene therapy. He works on developing efficient, reproducible, and safe cGMP processes for manufacturing AAV-based gene therapies. He is also involved in evaluating and implementing new process innovations to support robust AAV manufacturing. The work was done during his internship with BridgeBio Gene Therapy during the summer of 2021 while he was pursuing his Ph.D. in Chemical Engineering at North Carolina State University.